Siltuximab (anti-IL-6) Interleukins null | Read Reviews & Product Use Citations

Siltuximab (anti-IL-6) (CNTO 328) is a human-mouse chimeric monoclonal antibody that binds human interleukin-6 (IL-6).

Click to purchase the isotype control of Siltuximab (anti-IL-6)

Purity & Quality Control

Batch: Purity: 99.93% Protein concentration: 5.6mg/ml Endotoxin Level: ＜1EU/mg

99.93

Choose Selective Interleukins Inhibitors

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description	Siltuximab (anti-IL-6) (CNTO 328) is a human-mouse chimeric monoclonal antibody that binds human interleukin-6 (IL-6).

References
[1] Jayaprakash Karkera, et al. Prostate . 2011 Sep 15;71(13):1455-65.

References

[1] Jayaprakash Karkera, et al. Prostate . 2011 Sep 15;71(13):1455-65.

Product Details

CAS No.	541502-14-1
Molecular Weight	145 kDa
Isotype	Human IgG1, κ
Source	CHO cells
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field